Mutational analyses of novel rat models with targeted modifications in inflammatory bowel disease susceptibility genes

Mamm Genome. 2021 Jun;32(3):173-182. doi: 10.1007/s00335-021-09868-2. Epub 2021 Apr 11.

Abstract

Mutations and single base pair polymorphisms in various genes have been associated with increased susceptibility to inflammatory bowel disease (IBD). We have created a series of rat strains carrying targeted genetic alterations within three IBD susceptibility genes: Nod2, Atg16l1, and Il23r, using CRISPR/Cas9 genome editing technology. Knock-out alleles and alleles with known human susceptibility polymorphisms were generated on three different genetic backgrounds: Fischer, Lewis and Sprague Dawley. The availability of these rat models will contribute to our understanding of the basic biological roles of these three genes as well as provide new potential IBD animal models.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • CRISPR-Cas Systems / genetics
  • Gene Editing
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Inflammatory Bowel Diseases / genetics*
  • Inflammatory Bowel Diseases / pathology
  • Mutation / genetics
  • Nod2 Signaling Adaptor Protein / genetics*
  • Polymorphism, Single Nucleotide / genetics
  • Rats
  • Receptors, Interleukin / genetics*
  • Vesicular Transport Proteins / genetics

Substances

  • NOD2 protein, rat
  • Nod2 Signaling Adaptor Protein
  • Receptors, Interleukin
  • Vesicular Transport Proteins
  • interleukin-23 receptor, rat
  • Atg16L1 protein, rat